ProtAffin appoints Pfizer's Mike Bartley CDO
This article was originally published in Scrip
Executive Summary
ProtAffin, a biotech developing a novel class of drugs for respiratory disease, inflammation and oncology, has appointed Dr Mike Bartley chief development officer, leading preclinical and clinical development activities. Dr Bartley previously served for 10 years at Pfizer, most recently as senior project leader for preclinical and clinical projects.